Simpson, E. ., Yosipovitch, G. ., Eyerich, K. ., Staumont-Sallé, D. ., Shahriari, M. ., Gallo, G. ., Wolf, E. ., Pierce, E. ., Liu, C. ., Zhong, J. ., Agell, H. ., & de Bruin-Weller, M. . (2023). Lebrikizumab Provides Rapid Response in EASI Components and Itch in Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, 7(6), s279. https://doi.org/10.25251/skin.7.supp.279